Healthcare Sales & Marketing Network News: placenta

Searching News Database: placenta

HSMN NewsFeed - 23 Dec 2020
FDA Approves Bracco Diagnostics Inc.'s ProHance(R) (Gadoteridol) Injection, 279.3 mg/mL, for Pediatric Patients Younger than Two Years
Biopharmaceuticals Radiology FDA

HSMN NewsFeed - 17 Nov 2020
Celularity Announces Appointments of Chief Medical Officer and Senior Vice President of Regulatory Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Oct 2020
Citius Pharmaceuticals Signs an Exclusive Worldwide Licensing Agreement with Novellus Therapeutics for Unique iMSC-Therapy for Acute Inflammatory Respiratory Conditions including COVID-19 Related Acute Respiratory Distress Syndrome (ARDS)
Biopharmaceuticals Regenerative Medicine Licensing

HSMN NewsFeed - 26 Jun 2020
Citius Receives FDA Response on Pre-Investigational New Drug (PIND) Application for its Induced Mesenchymal Stem Cells (iMSCs) to Treat Acute Respiratory Distress Syndrome (ARDS) in Patients with COVID-19
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Jan 2020
Celularity Announces FDA Clearance of Landmark IND for CYNK-001, an Allogeneic, Off-the-Shelf Cryopreserved NK Cell Therapy
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 13 Aug 2019
FDA Approves EYLEA(R) (aflibercept) Injection Prefilled Syringe
Biopharmaceuticals Drug Delivery Ophthalmology FDA

HSMN NewsFeed - 9 May 2019
MiMedx Appoints Timothy R. Wright as Chief Executive Officer
Devices Wound Care Personnel

HSMN NewsFeed - 12 Mar 2019
Smith & Nephew expands in high growth regenerative medicine market through acquisition of Osiris Therapeutics, Inc.
Devices Orthopaedic Mergers & Acquisitions

HSMN NewsFeed - 5 Dec 2018
MiMedx Announces Leadership Changes And Promotions
Biopharmaceuticals Regenerative Medicine Personnel

HSMN NewsFeed - 5 Dec 2018
MiMedx Announces Organizational Realignment Program
Biopharmaceuticals Regenerative Medicine Personnel

HSMN NewsFeed - 25 Oct 2018
EYLEA(R) (aflibercept) Injection Improves Diabetic Retinopathy and Reduces Vision-Threatening Complications in Phase 3 Trial
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 13 Sep 2018
FDA to Review EYLEA (aflibercept) Injection for the Treatment of Diabetic Retinopathy
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 17 Aug 2018
FDA Approves EYLEA(R) (aflibercept) Injection sBLA in Wet Age-related Macular Degeneration
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 13 Aug 2018
Regeneron Provides Regulatory Update on EYLEA(R) (aflibercept) Injection sBLA in Wet Age-Related Macular Degeneration
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 9 Aug 2018
MiMedx Receives Regulatory Approval to Commercialize Product Portfolio in Australia
Devices Regenerative Medicine Regulatory

HSMN NewsFeed - 27 Jun 2018
Adicet Bio appoints Stewart Abbot, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 7 Jun 2018
MiMedx Announces Executive to Lead its International Operations and Provides Update on Company's International Progress
Biopharmaceuticals Regenerative Medicine Personnel

HSMN NewsFeed - 29 May 2018
UCB Announces the Approval of CIMZIA(R) (certolizumab pegol) for Moderate-to-Severe Plaque Psoriasis, Representing an Important New Option for Patients in the U.S.
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 19 Mar 2018
EYLEA(R) (aflibercept) Injection Demonstrates Positive Topline Results in Phase 3 Non-Proliferative Diabetic Retinopathy Trial
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 11 Dec 2017
Regeneron Announces FDA Acceptance of sBLA Filing for 12-Week Dosing of EYLEA(R) (aflibercept) Injection for Patients with Wet AMD
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 27 Nov 2017
Regeneron Provides Update on EYLEA(R) (aflibercept) Injection and Nesvacumab (Ang2 Antibody) Combination Program
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 21 Nov 2017
MiMedx Provides Update On Its Reimbursement Coverage
Regenerative Medicine Reimbursement

HSMN NewsFeed - 17 Nov 2017
MiMedx Market Leadership Well Positioned In Light Of FDA New Guidance Document
Regenerative Medicine FDA

HSMN NewsFeed - 1 Nov 2017
MiMedx Agrees To Lawsuit Settlement With Halo Wound Solutions
Devices Regenerative Medicine Wound Care Litigation

HSMN NewsFeed - 3 Oct 2017
Dr. Gloria Matthews Joins MiMedx As Its Senior Vice President Of Research And Development
Devices Regenerative Medicine Personnel

HSMN NewsFeed - 7 Sep 2017
MiMedx Notified By FDA That It Can Proceed With Phase 3 Investigational New Drug Clinical Trial For Achilles Tendonitis
Biopharmaceuticals Regenerative Medicine Orthopaedic FDA

HSMN NewsFeed - 31 Aug 2017
MiMedx Reports MultiCenter randomized Controlled VLU Clinical Study Accepted for Publication in The International Wound Journal
Biopharmaceuticals Regenerative Medicine Wound Care

HSMN NewsFeed - 7 Aug 2017
Impax Announces Settlement of Contract Litigation on Opana(R) ER (Oxymorphone Hydrochloride) CII Extended-Release Tablets
Biopharmaceuticals Litigation

HSMN NewsFeed - 31 Mar 2017
Osiris Therapeutics Launches Prestige(TM) Lyotechnology, a Novel Method for Ambient Storage of Living Cells and Tissues
Regenerative Medicine Product Launch

HSMN NewsFeed - 20 Jan 2017
Osiris Therapeutics announced a Comparative Effectiveness Study on the Use of Two Human Placental Membranes in Wound Management is Available Electronically in a Peer-Reviewed Journal
Devices Wound Care

HSMN NewsFeed - 12 Jan 2017
Derma Sciences Buys MEDIHONEY(R) Brand From Long-Term Partner
Regenerative Medicine Wound Care Acquisitions

HSMN NewsFeed - 14 Sep 2016
European Commission Approves CABOMETYX(TM) (cabozantinib) Tablets for the Treatment of Advanced Renal Cell Carcinoma Following VEGF-Targeted Therapy
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 18 Aug 2016
Derma Sciences Names Russell Olsen President of Advanced Wound Care
Regenerative Medicine Wound Care Dermatology Personnel

HSMN NewsFeed - 28 Jul 2016
Derma Sciences to Acquire BioD, Solidify Its Leadership Position in Advanced Wound Care and Regenerative Products
Regenerative Medicine Wound Care Mergers & Acquisitions

HSMN NewsFeed - 25 Jul 2016
MiMedx Announces Nationwide Launch of New Ambient Temperature Version of OrthoFlo
Devices Regenerative Medicine Product Launch

HSMN NewsFeed - 17 May 2016
MiMedx Files Lawsuit Against Osiris For False And Misleading Representations
Regenerative Medicine Wound Care Litigation

HSMN NewsFeed - 29 Jan 2016
Human Regenerative Technologies, LLC (HRT) Announce WoundEx(R) Amniotic Membrane Products Receive Coverage From Novitas Solutions, Inc.
Devices Regenerative Medicine Reimbursement

HSMN NewsFeed - 19 Nov 2015
AMNIOX Highlights Study Showing Eighty Percent of Patients With Lower-extremity Ulcers Achieve Healing When Treated with NEOX(R) Wound Allograft
Devices Wound Care

HSMN NewsFeed - 30 Oct 2015
Regeneron Announces EU Approval of EYLEA(R) (aflibercept) Injection for the Treatment of Visual Impairment Secondary to Myopic Choroidal Neovascularization
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 12 Aug 2015
Japan Grants Safety Clearance to Pluristem's PLX-PAD Cells for Use in Clinical Trials
Regenerative Medicine Regulatory

HSMN NewsFeed - 15 Jul 2015
Fate Therapeutics Appoints Dr. Stewart Abbot as Vice President, Translational Research
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Jun 2015
EYLEA(R) (aflibercept) Injection Receives Approval in Japan for the Treatment of Retinal Vein Occlusion
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 26 Feb 2015
EYLEA(R) (aflibercept) Injection Receives EU Approval for the Treatment of Visual Impairment Due to Macular Edema Secondary to Retinal Vein Occlusion
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 7 Nov 2014
MiMedx(R) Adds New Executive
Regenerative Medicine Personnel

HSMN NewsFeed - 17 Oct 2014
EYLEA(R) (aflibercept) Injection Demonstrates Significantly Greater Gains in Visual Acuity than Both Bevacizumab and Ranibizumab in NIH-Sponsored Diabetic Macular Edema Study
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 22 Sep 2014
Regeneron Announces EYLEA(R) (aflibercept) Injection Approved for the Treatment of Patients with Myopic Choroidal Neovascularization (CNV) in Japan
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 11 Aug 2014
EYLEA(R) (aflibercept) Injection Receives EU Approval for the Treatment of Diabetic Macular Edema (DME)
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 29 Jul 2014
AMNIOX(R) Medical Announces Initiation of Prospective, Randomized, Controlled Clinical Study of Chronic Wounds
Regenerative Medicine Wound Care

HSMN NewsFeed - 27 Jun 2014
EYLEA(R) (aflibercept) Injection Recommended for Approval for the Treatment of Visual Impairment due to Diabetic Macular Edema in the European Union
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 9 Jun 2014
Batu Biologics Announces FDA Development Plans for ValloVax(TM) Angiogenesis-Targeting Cancer Vaccine
Biopharmaceuticals Oncology

HSMN NewsFeed - 4 Mar 2014
ThromboGenics Initiates Major Post-Marketing Patient Trial with JETREA(R) in the US
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 10 Feb 2014
Two-Year Results From Phase 3 VISTA Trial of EYLEA(R) (aflibercept) Injection for the Treatment of Diabetic Macular Edema Show Sustained Improvement in Vision
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 5 Feb 2014
Pluristem Strengthens Executive Team; Announces Senior Executive Appointments
Regenerative Medicine Personnel

HSMN NewsFeed - 21 Jan 2014
Pluristem's Phase I/II Muscle Injury Trial Successfully Meets Primary Safety & Efficacy Endpoints
Regenerative Medicine Orthopaedic

HSMN NewsFeed - 14 Jan 2014
Derma Sciences Enters the Skin Substitute Market with Licensing Agreement for Innovative Amniotic Membrane Wound Care Products
Devices Wound Care Licensing

HSMN NewsFeed - 18 Dec 2013
Regeneron Announces FDA Acceptance of EYLEA(R) (aflibercept) Injection Supplemental Biologics License Application for Review for Diabetic Macular Edema Indication
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 12 Dec 2013
MiMedx Receives Additional Medicare Reimbursement Coverage for EpiFix(R)
Devices Regenerative Medicine Wound Care Reimbursement

HSMN NewsFeed - 3 Dec 2013
J-Code for ThromboGenics' JETREA to Become Effective January 1, 2014
Biopharmaceuticals Ophthalmology Reimbursement

HSMN NewsFeed - 29 Nov 2013
Osiris Provides Update on Proposed Ruling by CMS
Devices Regenerative Medicine Wound Care Reimbursement

HSMN NewsFeed - 22 Nov 2013
EYLEA(R) (aflibercept) Injection Approved For The Treatment of Macular Edema Following Central Retinal Vein Occlusion In Japan
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 12 Nov 2013
Bayer receives approval for Eylea(R) as new drug to treat wet Age-Related Macular Degeneration Patients in Canada
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 1 Oct 2013
MiMedx Signs Distribution Agreement With Medtronic
Devices Orthopaedic Neurosurgery Distribution

HSMN NewsFeed - 5 Sep 2013
GSK�s MAGE-A3 Cancer Immunotherapeutic Phase 3 Study in Melanoma Misses First Co-Primary Endpoint
Biopharmaceuticals Oncology

HSMN NewsFeed - 5 Sep 2013
ThromboGenics Acquires Exclusive Rights from Bicycle Therapeutics to Develop and Commercialize Novel Drugs Inhibiting a Target for Diabetic Macular Edema
Biopharmaceuticals Ophthalmology Licensing

HSMN NewsFeed - 2 Sep 2013
UK's NICE Final Appraisal Determination (FAD) Confirms Positive Recommendation for ThromboGenics' JETREA(R) for Treatment of Vitreomacular Traction and Macular Hole
Biopharmaceuticals Ophthalmology Regulatory Reimbursement

HSMN NewsFeed - 2 Aug 2013
Germany's IQWiG Confirms That ThromboGenics' JETREA(R) Demonstrates Major Added Value for the Treatment of Vitreomacular Traction and Macular Hole
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 26 Jul 2013
EYLEA(R) (aflibercept) Injection Recommended for Approval for the Treatment of Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion in Europe
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 26 Jun 2013
Pluristem Enters Into Strategic Partnership and Licensing Agreement With Cha Bio&Diostech for the Development and Commercialization of PLX Cells for the Treatment of CLI and IC in South Korea
Regenerative Medicine Licensing

HSMN NewsFeed - 12 Jun 2013
ThromboGenics' JETREA(R) Receives Positive Initial NICE Recommendation for Vitreomacular Traction and Macular Hole
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 18 Apr 2013
Pluristem Expands PLX Product Portfolio in Orthopedics and Sports Medicine
Regenerative Medicine Orthopaedic

HSMN NewsFeed - 1 Mar 2013
Osiris Therapeutics Establishes Direct Sales Force for Grafix(R)
Devices Regenerative Medicine Wound Care Distribution

HSMN NewsFeed - 19 Feb 2013
Regeneron and Bayer Initiate Phase 3 Trial of EYLEA(R) (aflibercept) Injection for the Treatment of Diabetic Macular Edema in Asia and Russia
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 8 Feb 2013
Data from St. Jude Medical RESPECT Trial for PFO Closure Highlighted at International Stroke Conference 2013
Devices Interventional Cardiology

HSMN NewsFeed - 5 Feb 2013
ZALTRAP(R) (ziv-aflibercept) Approved in the EU for Patients with Previously Treated Metastatic Colorectal Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 18 Jan 2013
ThromboGenics Receives Positive CHMP Opinion for JETREA(R)
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 4 Jan 2013
ThromboGenics Confirms JETREA(R) US Launch Date of Monday January 14th, 2013
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 6 Dec 2012
EYLEA(R) (aflibercept) Submitted for EU Marketing Authorization for the Treatment of Macular Edema Following Central Retinal Vein Occlusion
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 27 Nov 2012
EYLEA(R) (aflibercept) Injection Approved for the Treatment of Wet Age-Related Macular Degeneration in Europe
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 18 Oct 2012
U.S. FDA Approves ThromboGenics' JETREA(R) (Ocriplasmin) for the Treatment of Symptomatic Vitreomacular Adhesion (VMA)
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 5 Sep 2012
Third Critically Ill Patient Successfully Treated With Pluristem's PLX Cells Under Compassionate Use
Regenerative Medicine Oncology

HSMN NewsFeed - 6 Aug 2012
Life of Cancer Patient Suffering From Bone Marrow Failure Saved Following Treatment With Pluristem's PLX Cells
Regenerative Medicine Oncology

HSMN NewsFeed - 30 Apr 2012
Pluristem Awarded a $3.1 Million Grant by Israeli Government
Regenerative Medicine

HSMN NewsFeed - 5 Apr 2012
Sanofi and Regeneron Announce Regulatory and Clinical Update for ZALTRAP(R) (aflibercept)
Biopharmaceuticals

HSMN NewsFeed - 8 Mar 2012
Regeneron and Bayer Announce Approval of EYLEA(R) (aflibercept) Injection for the Treatment of Wet Age-Related Macular Degeneration in Australia
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 3 Nov 2011
Pluristem Announces Positive 12-Month Data From the Use of PLX-PAD for the Treatment of Critical Limb Ischemia
Regenerative Medicine

HSMN NewsFeed - 6 Jun 2011
ZALTRAP (aflibercept) Significantly Improved Survival in Previously Treated Metastatic Colorectal Cancer Patients
Biopharmaceuticals Oncology

HSMN NewsFeed - 18 Apr 2011
FDA Grants Priority Review for VEGF Trap-Eye for the Treatment of Wet Age-Related Macular Degeneration
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 8 Apr 2011
Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 10 Mar 2011
Sanofi-aventis and Regeneron Report Top-line Results from Phase III Study with aflibercept (VEGF Trap) in Second-Line Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 20 Dec 2010
Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and in Phase 2 Study in Diabetic Macular Edema (DME)
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 27 Oct 2010
PerkinElmer Releases DELFIA(R) Xpress PlGF Assay for Early Detection of Pre-eclampsia in Pregnant Women
Diagnostics

HSMN NewsFeed - 7 Jan 2010
Miraculins Announces Partnership With Inverness Medical Innovations to Develop a Diagnostic Test for Preeclampsia
Diagnostics

HSMN NewsFeed - 23 Sep 2009
Pluristem Therapeutics Doses First Patient in U.S. With Placenta-Derived Stem Cell Product PLX-PAD in a Phase I Clinical Trial for Treatment of Peripheral Artery Disease
Regenerative Medicine

HSMN NewsFeed - 10 Sep 2009
Pluristem Begins Enrollment in U.S. With Unmatched Placenta-Derived Stem Cell Product PLX-PAD in a Phase I Clinical Trial for Treatment of Peripheral Artery Disease
Regenerative Medicine

HSMN NewsFeed - 16 Jun 2009
Pluristem Therapeutics Receives European Regulatory Approval for Placental-Derived Stem Cell Clinical Trial
Regenerative Medicine

HSMN NewsFeed - 8 May 2009
New Data Shows Blood Pressure Reduction Therapy With BENICAR(R) and BENICAR HCT(R) Effectively Reduces Blood Pressure in Elderly Patients to Target Blood Pressure
Biopharmaceuticals

HSMN NewsFeed - 30 Apr 2009
Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 6 Nov 2008
FDA Approves Additional Indication for Norditropin(R) for Small for Gestational Age (SGA) in Children
Biopharmaceuticals FDA

HSMN NewsFeed - 4 Nov 2008
FDA Approves Additional Indication for Norditropin(R) for Small for Gestational Age (SGA) in Children
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 19 Aug 2008
Regeneron and Bayer HealthCare Announce VEGF Trap-Eye Achieved Durable Improvement in Vision over 52 Weeks in a Phase 2 Study in Patients with Age-Related Macular Degeneration
Biopharmaceuticals Opthalmology

HSMN NewsFeed - 4 Aug 2008
Pluristem Appoints Ms. Chaya Mazouz Clinical Operations Director
Regenerative Medicine Personnel

HSMN NewsFeed - 16 Jun 2008
New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering
Biopharmaceuticals

HSMN NewsFeed - 14 May 2008
New Data Shows 45 Percent of Patients With Stage 1 Hypertension Reached Normotension With BENICAR(R) and BENICAR HCT(R)
Biopharmaceuticals

HSMN NewsFeed - 8 May 2008
Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 28 Apr 2008
Regeneron and Bayer HealthCare Announce Encouraging 32-Week Follow-Up Results from a Phase 2 Study of VEGF Trap-Eye in Age-Related Macular Degeneration
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 4 Mar 2008
Pluristem Submits Pre-IND Application in Germany to Initiate Clinical Trials of PLX-PAD for Peripheral Artery Disease
Regenerative Medicine Regulatory

HSMN NewsFeed - 8 Jan 2008
Pluristem Announces Second Clinical Indication Revascularization Effect After PLX-PAD Therapy
Regenerative Medicine

HSMN NewsFeed - 27 Dec 2007
Sequenom Announces New York State Approval of a Noninvasive Prenatal Test
Diagnostics

HSMN NewsFeed - 15 Nov 2007
PerkinElmer Completes Acquisition of ViaCell
Regenerative Medicine Mergers & Acquisitions

HSMN NewsFeed - 1 Oct 2007
PerkinElmer to Expand Genetic Screening Business Through Acquisition of ViaCell
Regenerative Medicine Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 23 Aug 2007
Phase 3 Oncology Program for Aflibercept (VEGF Trap) Initiated by Regeneron and sanofi-aventis
Biopharmaceuticals Oncology

HSMN NewsFeed - 2 Aug 2007
Regeneron and Bayer HealthCare Initiate Phase 3 Global Development Program For VEGF Trap-Eye In Wet Age-Related Macular Degeneration (AMD)
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 27 Jun 2007
Beckman Coulter Grants Sublicense to Dade Behring for Novel Cardiac Markers
Diagnostics Licensing

HSMN NewsFeed - 21 May 2007
BENICAR HCT(R) Reductions in Seated Systolic Blood Pressure for Stage 2 Patients Compared With Amlodipine + Benazepril
Biopharmaceuticals Cardiology

HSMN NewsFeed - 9 May 2007
VEGF Trap-Eye Phase 2 Wet AMD Results Reported at ARVO Annual Meeting
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 14 Feb 2007
Pluristem Announces Private Equity Investment of $8M
Regenerative Medicine Venture Capital

HSMN NewsFeed - 16 Jan 2007
Pluristem Appoints Dr. William R. Prather as Senior VP of Corporate Development
Regenerative Medicine Personnel

HSMN NewsFeed - 4 Jan 2007
Medistem Laboratories Appoints Thomas Ichim to Be Chief of Scientific Development
Regenerative Medicine Personnel

HSMN NewsFeed - 20 Dec 2006
Regeneron Reports Blocking New Angiogenesis Target May Offer Novel Approach to Slowing Tumor Growth
Biopharmaceuticals Oncology

HSMN NewsFeed - 31 Oct 2006
Pluristem Expects to Submit Pre-IND Document to FDA by End of 2006
Regenerative Medicine

HSMN NewsFeed - 26 Oct 2006
NeoStem, Inc. Appoints Julio C. Guerra, MD, ABP, as Director of Sales and Marketing
Regenerative Medicine Personnel

HSMN NewsFeed - 18 Oct 2006
Bayer HealthCare and Regeneron to Collaborate on VEGF Trap for the Treatment of Eye Diseases
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 20 Jul 2006
OVATION Pharmaceuticals Announces First New Drug Treatment in 20 Years for Premature Infants with Patent Ductus Arteriosus
Biopharmaceuticals Cardiology

HSMN NewsFeed - 25 Apr 2006
FDA Approves Humanitarian Device Exemption for Instrument Set to Treat Rare Disorder Affecting Fetal Twins -- KARL STORZ Device Offers Unique Treatment Option for Twin-to-Twin Transfusion Syndrome
Devices FDA

HSMN NewsFeed - 16 Mar 2006
Medistem Appoints Accomplished Physician and Medical Entrepreneur Roger M. Nocera, MD, as Executive VP and CMO
Regenerative Medicine Personnel

HSMN NewsFeed - 6 Mar 2006
Pluristem Strengthens Business Strategy, Company to Focus on Commercializing Cell Therapy Products
Biopharmaceuticals Regenerative Medicine

HSMN NewsFeed - 2 Feb 2006
Regeneron's VEGF Trap Demonstrates Positive Preliminary Results in Patients with Age-Related Macular Degeneration
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 10 Jan 2006
Dade Behring Grants Sublicense to Abbott for the Use of Placental Growth Factor (PlGF) for the Diagnosis of Cardiovascular Diseases
Diagnostics Licensing Cardiology

Return to NewsFeed

Additional items found! 28

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 28 additional stories matching:
placenta
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.